🔴 Conexeu Sciences is trading 11.08% down today as biotech and major indexes fell

Conexeu Sciences is trading 11.08% down at $6.38 as broad risk-off pressure weighs on U.S. equities and biotechnology shares on September 1, 2026.

• Nasdaq Composite: down 0.92%; S&P 500: down 0.53%; biotech ETF XBI: down 4.24%.
• No clear company-specific announcement or filing explains the decline.
• Recent materials focus on its preclinical platform and planned early-2027 FDA submission, rather than a new negative catalyst.